COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings.

Narayanan, Shivakumar; Chua, Joel V; Heil, Emily

Narayanan, Shivakumar; Chua, Joel V; Heil, Emily.

Narayanan S; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. snarayanan@ihv.umaryland.edu.
Chua JV; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Heil E; University of Maryland School of Pharmacy, Baltimore, MD, USA.

J Gen Intern Med ; 35(11): 3359-3360, 2020 11.

Article in English | MEDLINE | ID: covidwho-743762

Subject(s)

COVID-19/therapy; Patient Selection/ethics; Randomized Controlled Trials as Topic/ethics; Attitude to Health; Biomedical Research/ethics; Ethics, Clinical; Humans; Research Subjects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Patient Selection / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Gen Intern Med Journal subject: Internal Medicine Year: 2020 Document Type: Article Affiliation country: S11606-020-06158-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google